XML 22 R7.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Stockholders' / Members' Equity - USD ($)
$ in Thousands
Total
Class A Units
Class B Units
Class C Units
Class D Units
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-In Capital
Distributions in Excess of Cumulative Earnings
Distributions in Excess of Cumulative Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Total Stockholders' /Members' Equity
Total Stockholders' /Members' Equity
Cumulative Effect, Period of Adoption, Adjustment
Non- Controlling Interests
Non- Controlling Interests
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance at Dec. 31, 2017 $ 181,402 $ 86,668 $ 574 $ 94,064 $ 96   $ 0 $ 0 $ 0   $ 0 $ 181,402   $ 0  
Beginning balance (in shares) at Dec. 31, 2017             0                
Contributions 50,000 50,000                   50,000      
Unit compensation expense 443   373   70             443      
Net income 4,285 2,414   1,871               4,285      
Ending balance at Jun. 24, 2018 236,130 139,082 947 95,935 166   $ 0 0 0   0 236,130   0  
Ending balance, (in shares) at Jun. 24, 2018             0                
Beginning balance at Dec. 31, 2017 181,402 86,668 574 94,064 96   $ 0 0 0   0 181,402   0  
Beginning balance (in shares) at Dec. 31, 2017             0                
Net income 20,614                            
Ending balance at Dec. 31, 2018 811,041 0 0 0 0   $ 431 569,407 (7,659)   0 562,179   248,862  
Ending balance, (in shares) at Dec. 31, 2018             43,749,092                
Beginning balance at Jun. 24, 2018 236,130 139,082 947 95,935 166   $ 0 0 0   0 236,130   0  
Beginning balance (in shares) at Jun. 24, 2018             0                
Contribution of Predecessor equity in exchange for OP Units 0 (139,082) (947) (95,935) (166)             (236,130)   236,130  
Initial public offering/common stock issuance 493,811           $ 353 493,458       493,811      
Initial public offering/common stock issuance (in shares)             35,272,191                
Concurrent private placement of common stock 108,999           $ 78 108,921       108,999      
Concurrent private placement of common stock, (in shares)             7,785,611                
Concurrent private placement of OP Units 16,001                         16,001  
Costs related to initial public offering (35,107)             (35,107)       (35,107)      
Share-based compensation expense 1,692             1,692       1,692      
Share-based compensation expense (in shares)             691,290                
Unit compensation expense 443             443       443      
Dividends declared on common stock and OP Units (27,257)               (18,987)     (18,987)   (8,270)  
Net income 16,329               11,328     11,328   5,001  
Ending balance at Dec. 31, 2018 811,041 0 0 0 0   $ 431 569,407 (7,659)   0 562,179   248,862  
Ending balance, (in shares) at Dec. 31, 2018             43,749,092                
Initial public offering/common stock issuance 423,687           $ 215 423,472       423,687      
Initial public offering/common stock issuance (in shares)             21,462,986                
Costs related to initial public offering (13,901)             (13,901)       (13,901)      
Conversion of equity in Secondary Offering 0           $ 185 237,795       237,980   (237,980)  
Conversion of equity in Secondary Offering, (in shares)             18,502,705                
Unrealized losses on cash flow hedges (2,799)                   (1,868) (1,868)   (931)  
Cash flow hedge gains (losses) reclassified to interest expense (106)                   (81) (81)   (25)  
Share-based compensation expense 4,115           $ 7 4,108       4,115      
Share-based compensation expense (in shares)             46,368                
Unit compensation expense 2,162             2,162       2,162      
Dividends declared on common stock and OP Units (70,111)               (61,667)     (61,667)   (8,444)  
Net income 48,025               41,844     41,844   6,181  
Ending balance at Dec. 31, 2019 $ 1,202,113 0 0 0 0 $ (188) $ 838 1,223,043 (27,482) $ (187) (1,949) 1,194,450 $ (187) 7,663 $ (1)
Ending balance, (in shares) at Dec. 31, 2019 83,761,151           83,761,151                
Initial public offering/common stock issuance $ 477,799           $ 225 477,574       477,799      
Initial public offering/common stock issuance (in shares)             22,554,057                
Costs related to initial public offering (18,154)             (18,154)       (18,154)      
Unrealized losses on cash flow hedges (42,121)                   (41,868) (41,868)   (253)  
Cash flow hedge gains (losses) reclassified to interest expense 6,676                   6,636 6,636   40  
Share-based compensation expense 6,078           $ 1 6,077       6,078      
Share-based compensation expense (in shares)             46,316                
Dividends declared on common stock and OP Units (92,783)               (92,269)     (92,269)   (514)  
Net income 42,528               42,273     42,273   255  
Ending balance at Dec. 31, 2020 $ 1,581,948 $ 0 $ 0 $ 0 $ 0   $ 1,064 $ 1,688,540 $ (77,665)   $ (37,181) $ 1,574,758   $ 7,190  
Ending balance, (in shares) at Dec. 31, 2020 106,361,524           106,361,524                
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201613Member